- Home
- / ViaMune
ViaMune
ViaMune Summary
Company Summary
- Overview
- ViaMune is a company engaged in the development of an immunotherapy vaccine. Its solutions targets tumor-specific MUC1, a cell-surface glycoprotein that helps cancerous cells form a barrier against chemotherapeutic drugs.
- Type
- Private
- Status
- Active
- Founded
- 2011
- Website
- http://www.viamune.com/
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026